Clinical Trial Update: Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa [NA]

View source ↗

Summary

A clinical trial (NCT07088705) evaluating Subthreshold Micropulse Laser Therapy for Retinitis Pigmentosa is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• Subthreshold Micropulse Laser Therapy

Snippet

Sponsor: Marta P. Wiącek | Conditions: Retinitis Pigmentosa (RP) | NA | Status: ENROLLING_BY_INVITATION